Concepedia

SA Piha-Paul

SP

Statistics

Publications

2

Citations

112

H-Index

2

Active since

2016

Affiliations

Dana-Farber Cancer Institute(Current)

SA Piha-Paul is an author at Dana-Farber Cancer Institute specializing in oncology, her2-positive breast cancer, and medicine.

Publications per year

2016–2016

2

Publications

2

Abstract S5-07: Preliminary efficacy and safety of pembrolizumab (MK-3475) in patients with PD-L1–positive, estrogen receptor-positive (ER+)/HER2-negative advanced breast cancer enrolled in KEYNOTE-028

HS Rugo, J.P. Delord, S-A. Im et al. · Cancer Research · 2016 · 97 citations

, , +17

Abstract PD5-05: Neratinib for <i>ERBB2</i> mutant, HER2 non-amplified, metastatic breast cancer: Preliminary analysis from a multicenter, open-label, multi-histology phase II basket trial

DM Hyman, SA Piha-Paul, Jordi Rodón et al. · Cancer Research · 2016 · 15 citations

, , +17

1–2 of 2